Williams & Novak »

Taysha Gene Therapies shares owned by Williams & Novak

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Williams & Novak from 13F filings

Historical chart of Williams & Novak investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Williams & Novak consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Williams & Novak

Quarter filed Position value Share count Share price at filing
2024-03-31 $80k 45k 1.77
2023-12-31 $80k 45k 1.77

More positions owned by Williams & Novak

Sypris Solutions (SYPR)
Pimco Equity Ser Rafi Dyn Ml Us (MFUS)
Ishares Tr Core 1 5 Yr Usd (ISTB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Calif Mun Bd Etf (CMF)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Pimco Etf Tr Active Bd Etf (BOND)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Msci Gbl Gold Mn (RING)
Pimco CA Municipal Income Fund (PCQ)
Apple (AAPL)
Ishares Tr International Sl (ISCF)
Ishares Silver Tr Ishares (SLV)
Ishares Tr Core Div Grwth (DGRO)

View all positions for Williams & Novak

Top funds holding Taysha Gene Therapies

RA Capital Management
VR Adviser
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Point72 Asset Management
Citadel Advisors
T. Rowe Price Associates
Schonfeld Strategic Advisors
Exome Asset Management
Alphabet
Quantum Private Wealth
Palo Alto Investors

View all funds holding Taysha Gene Therapies